Back to search
FDAFDA · Food and drugs·Recall number D-0290-2015

GENTAMICIN INJECTION, USP, equivalent to 40 mg/mL, Rx only, 20 mL Multiple Dose Vial, Manufactured by APP Pharmaceuticals, LLC, Schaumburg, IL 60173, NDC 63323-010-20

Published December 17, 2014 · Recall initiated: November 12, 2014

Summary

FDA records drug Class II recall D-0290-2015, published December 17, 2014 and initiated November 12, 2014. Recalling firm: Fresenius Kabi USA, LLC; Status: Terminated; Reported quantity: 92,125 vials; Lot: Product Code: 1020; NDC: 63323-010-20; Lot Number: 6107992; Expiration Date: 09/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Container: Vials may be missing stoppers.

What to do

Voluntary: Firm initiated · Letter

Get an email if GENTAMICIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
GENTAMICIN
Manufacturer
Fresenius Kabi USA, LLC
Distributor
Nationwide and Puerto Rico
UPC
0363323010034
Lot
Product Code: 1020; NDC: 63323-010-20; Lot Number: 6107992; Expiration Date: 09/2015
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was GENTAMICIN INJECTION, USP, equivalent to 40 mg/mL, Rx only, 20 mL Multiple Dose Vial, Manufactured by APP Pharmaceuticals, LLC, Schaumburg, IL 60173, NDC 63323-010-20 recalled?

Yes. FDA published recall D-0290-2015 on December 17, 2014. Reported hazard: Defective Container: Vials may be missing stoppers.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: GENTAMICIN. UPC: 0363323010034.